| For: | Xing ZY, Zhang CJ, Liu LJ. Targeting both ferroptosis and pyroptosis may represent potential therapies for acute liver failure. World J Gastroenterol 2024; 30(33): 3791-3798 [PMID: 39351426 DOI: 10.3748/wjg.v30.i33.3791] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i33/3791.htm |
| Number | Citing Articles |
| 1 |
Bohuai Tang, Zengbin Wang. Doxorubicin-induced hepatotoxicity: a multifaceted pathogenesis from mitochondrial collapse to immune remodeling and epigenetic memory. Archives of Toxicology 2026; doi: 10.1007/s00204-026-04534-5
|
| 2 |
Huazhu Wei, Shubing Yuan, Ziyuan Liang, Qinglan Shi. Integrated transcriptomic and experimental validation reveal that N‑acetylcysteine ameliorates acute liver failure through multi‑target synergistic regulation of pyroptosis and related signaling networks. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; doi: 10.1007/s00210-026-05678-y
|
| 3 |
Xinying Zhang, Chunmeng Fu, Ziyue Yang, Yue Tan, Huan Li, Xiangqian Zhang, Mengru Chen, Fang Peng, Ning Li. Bioinformatics-Guided Experimental Validation Identifies NQO1 as a Senescence-Ferroptosis Hub in Liver Fibrosis. Biomedicines 2025; 13(5) doi: 10.3390/biomedicines13051249
|
| 4 |
Jinyong He, Cong Du, Cuiping Li, Wei Li, Jinlan Qiu, Mingpeng Ma, Yunhao Chen, Qi Zhang. Ferroptosis in acute liver Failure: Unraveling the hepcidin-ferroportin axis and therapeutic interventions. Redox Biology 2025; 84 doi: 10.1016/j.redox.2025.103657
|